Skip to main content
. Author manuscript; available in PMC: 2019 Dec 28.
Published in final edited form as: Mol Pharm. 2019 Feb 15;16(3):1412–1420. doi: 10.1021/acs.molpharmaceut.8b01278

Figure 5.

Figure 5.

Gel electrophoresis of SiR-LDFC-trastuzumab visualized by (A) fluorescence imaging at 633 nm and (B) Coomassie staining. (C) Confocal microscopy images of SKOV-3 cells treated with SiR-LDFC-trastuzumab (red, SiR; blue, Hoechst 33342). Scale bar represents 60 μm.